COvid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial

DiscussionCOVIT-TRIAL is to our knowledge the first randomized controlled trial testing the effect of vitamin D supplementation on the prognosis of COVID-19 in high-risk older patients. High-dose vitamin D supplementation may be an effective, well-tolerated, and easily and immediately accessible treatment for COVID-19, the incidence of which increases dramatically and for which there are currently no scientifically validated treatments.Trial registrationClinicalTrials.govNCT04344041. Registered on 14 April 2020Trial statusRecruiting. Recruitment is expected to be completed in April 2021.
Source: Trials - Category: Research Source Type: clinical trials